UNLABELLED: Doxorubicin, a potent anthracycline used in chemotherapy, is limited by dose-dependent cardiotoxicity, leading to irreversible heart damage and heart failure. Common symptoms include fatigue, dyspnea, lower limb edema, hypotension, tachycardia, and transient arrhythmias. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40203-025-00333-5.